Baxter International (BAX) EBIT (2009 - 2026)

Baxter International (BAX) has 18 years of EBIT data on file, last reported at $66.0 million in Q1 2026.

• EBIT for Q1 2026 came in at $66.0 million, up 13.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.1 billion (down 31.32% YoY), and the FY2025 annual result was -$308.0 million, down 2300.0% from the prior year.
• EBIT improved to $66.0 million in Q1 2026 per BAX's latest filing, from $58.0 million in the prior quarter.
• Over five years, EBIT peaked at $1.0 billion in Q3 2024 and troughed at -$2.9 billion in Q3 2022.
• A 5-year average of $91.1 million and a median of $146.0 million in 2022 frame the typical range for EBIT.
• The sharpest annual moves came in 2022 and 2024: EBIT sank 1456.52% in 2022, then surged 6164.71% in 2024.
• A 5-year view of EBIT shows it stood at -$312.0 million in 2022, then soared by 307.05% to $646.0 million in 2023, then surged by 48.45% to $959.0 million in 2024, then slumped by 93.95% to $58.0 million in 2025, then advanced by 13.79% to $66.0 million in 2026.
• Business Quant data shows BAX's EBIT at $66.0 million in Q1 2026, $58.0 million in Q1 2025, and $959.0 million in Q4 2024.